Literature DB >> 367856

The influence of amyloid deposits on the islet volume in maturity onset diabetes mellitus.

P Westermark, E Wilander.   

Abstract

Pancreatic islet volumes of patients with and without maturity onset diabetes mellitus were estimated. The islet volume of the diabetic patients was 1.01 +/- 0.12 cm3 (SEM) and that of the non-diabetic patients 1.60 +/- 0.16 cm3 with considerable overlap between the two groups. Islet amyloidosis was found in all the diabetic and in 9 of the 15 non-diabetic patients. When the amyloid deposits were excluded, the islet volume of the diabetic patients was 0.89 +/- 0.10 cm3, while that of the non-diabetic patients was unchanged, 1.60 +/- 0.16 cm3. There was still some overlapping. Since amyloid deposits seem to destroy the B cell membranes, it was postulated that a comparison of the volumes of islets completely free of amyloid might give a more true picture of the quantitative islet alterations in maturity onset diabetes. It was found that this islet volume of the diabetics was only 0.41 +/- 0.05 cm3 and that of the non-diabetic patients 1.58 +/- 0.16 cm3. These values correspond better to the altered insulin secretion in maturity-onset diabetes mellitus.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 367856     DOI: 10.1007/bf01219652

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  14 in total

1.  Hyalinization of the islets of Langerhans in nondiabetic individuals.

Authors:  E T BELL
Journal:  Am J Pathol       Date:  1959 Jul-Aug       Impact factor: 4.307

2.  Principles and methods for the morphometric study of the lung and other organs.

Authors:  E R WEIBEL
Journal:  Lab Invest       Date:  1963-02       Impact factor: 5.662

3.  [Histopathological changes of the islands of Langerhans and their importance in the problem of the pathogenesis of human diabetes].

Authors:  W GEPTS
Journal:  Endokrinologie       Date:  1958-07

4.  [Contribution to the morphological study of the islands of Langerhans in diabetes; study of the quantitative variations of the different insular constituents].

Authors:  W GEPTS
Journal:  Ann Soc R Sci Med Nat Brux       Date:  1957

5.  Quantitative studies on amyloid in the islets of Langerhans.

Authors:  P Westermark
Journal:  Ups J Med Sci       Date:  1972       Impact factor: 2.384

6.  [On occurrence of island amyloidosis of the pancreas in diabetes mellitus].

Authors:  G Ludwig; H Heitner
Journal:  Z Gesamte Inn Med       Date:  1967-12-15

7.  Pathologic anatomy of the pancreas in juvenile diabetes mellitus.

Authors:  W Gepts
Journal:  Diabetes       Date:  1965-10       Impact factor: 9.461

8.  The pancreatic islet cells in insular amyloidosis in human diabetic and non-diabetic adults.

Authors:  P Westermark; L Grimelius
Journal:  Acta Pathol Microbiol Scand A       Date:  1973-05

9.  Amyloidosis of the islets of Langerhans. A restudy of islet hyalin in diabetic and non-diabetic individuals.

Authors:  J C EHRLICH; I M RATNER
Journal:  Am J Pathol       Date:  1961-01       Impact factor: 4.307

10.  ON THE RELATION OF CHRONIC INTERSTITIAL PANCREATITIS TO THE ISLANDS OF LANGERHANS AND TO DIABETES MELUTUS.

Authors:  E L Opie
Journal:  J Exp Med       Date:  1901-01-15       Impact factor: 14.307

View more
  85 in total

Review 1.  Developmental aspects of the endocrine pancreas.

Authors:  Daniel M Kemp; Melissa K Thomas; Joel F Habener
Journal:  Rev Endocr Metab Disord       Date:  2003-03       Impact factor: 6.514

Review 2.  Islet amyloid polypeptide--a novel controversy in diabetes research.

Authors:  P Westermark; K H Johnson; T D O'Brien; C Betsholtz
Journal:  Diabetologia       Date:  1992-04       Impact factor: 10.122

Review 3.  Pathogenesis of type 2 (non-insulin dependent) diabetes mellitus: a balanced overview.

Authors:  R A DeFronzo
Journal:  Diabetologia       Date:  1992-04       Impact factor: 10.122

4.  Age-related volumetric changes in pancreas: a stereological study on computed tomography.

Authors:  Veli Caglar; Ahmet Songur; Murat Yagmurca; Murat Acar; Muhsin Toktas; Yucel Gonul
Journal:  Surg Radiol Anat       Date:  2012-06-09       Impact factor: 1.246

Review 5.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

6.  The life story of the pancreatic B cell.

Authors:  C Hellerström
Journal:  Diabetologia       Date:  1984-06       Impact factor: 10.122

7.  Diminished B cell secretory capacity in patients with noninsulin-dependent diabetes mellitus.

Authors:  W K Ward; D C Bolgiano; B McKnight; J B Halter; D Porte
Journal:  J Clin Invest       Date:  1984-10       Impact factor: 14.808

8.  Secretory Functions of Macrophages in the Human Pancreatic Islet Are Regulated by Endogenous Purinergic Signaling.

Authors:  Jonathan R Weitz; Carol Jacques-Silva; Mirza Muhammed Fahd Qadir; Oliver Umland; Elizabeth Pereira; Farhan Qureshi; Alejandro Tamayo; Juan Dominguez-Bendala; Rayner Rodriguez-Diaz; Joana Almaça; Alejandro Caicedo
Journal:  Diabetes       Date:  2020-04-03       Impact factor: 9.461

9.  Matrix metalloproteinase-9 reduces islet amyloid formation by degrading islet amyloid polypeptide.

Authors:  Kathryn Aston-Mourney; Sakeneh Zraika; Jayalakshmi Udayasankar; Shoba L Subramanian; Pattie S Green; Steven E Kahn; Rebecca L Hull
Journal:  J Biol Chem       Date:  2012-12-10       Impact factor: 5.157

10.  Oxidative stress is induced by islet amyloid formation and time-dependently mediates amyloid-induced beta cell apoptosis.

Authors:  S Zraika; R L Hull; J Udayasankar; K Aston-Mourney; S L Subramanian; R Kisilevsky; W A Szarek; S E Kahn
Journal:  Diabetologia       Date:  2009-01-16       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.